Lu F. Si

Lu F. Si

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 188 publications

Immunotherapy for patients with melanoma in East Asia: current evidence, future directions, and clinical implications.

Immunotherapy for patients with melanoma in East Asia: current evidence, future directions, and clinical implications.

Journal: Expert opinion on biological therapy

Published: April 30, 2026

Expert consensus on the detection and clinical application of tumor mutational burden.

Expert consensus on the detection and clinical application of tumor mutational burden.

Journal: Cancer biology & medicine

Published: February 18, 2026

Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 study.

Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 study.

Journal: BMC medicine

Published: January 20, 2026

Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma.

Sonazoid-enhanced ultrasound for preoperative localization and characterization of sentinel lymph nodes in patients with cutaneous melanoma.

Journal: European radiology

Published: November 28, 2025

Anti-PD-1 matches interferon as adjuvant therapy for acral melanoma: a retrospective study.

Anti-PD-1 matches interferon as adjuvant therapy for acral melanoma: a retrospective study.

Journal: Therapeutic advances in medical oncology

Published: October 30, 2025

Long-term survival benefit of neoadjuvant oncolytic virus plus PD-1 blockade in acral melanoma: implications of STING in resistance and potential therapy.

Long-term survival benefit of neoadjuvant oncolytic virus plus PD-1 blockade in acral melanoma: implications of STING in resistance and potential therapy.

Journal: Experimental hematology & oncology

Published: October 13, 2025

A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma.

A phase II peri-operative study of pembrolizumab plus lenvatinib for mucosal melanoma.

Journal: Nature communications

Published: August 08, 2025

MARCO+ Tumor-Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma.

MARCO+ Tumor-Associated Macrophages Impede CD8+ T Cell Immunity to Facilitate Immunotherapy Resistance in Renal Cell Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 31, 2025

Disitamab vedotin with or without PD-1 inhibitors in pretreated patients with locally advanced or metastatic urothelial carcinoma: Identifying patients who derive additional benefit from immune combination therapy.

Disitamab vedotin with or without PD-1 inhibitors in pretreated patients with locally advanced or metastatic urothelial carcinoma: Identifying patients who derive additional benefit from immune combination therapy.

Journal: Urologic oncology

Published: June 30, 2025

Synergistic antitumor immune activation in melanoma using LA-PegPI polymeric gene vaccine in conjunction with PD-1 inhibition.

Synergistic antitumor immune activation in melanoma using LA-PegPI polymeric gene vaccine in conjunction with PD-1 inhibition.

Journal: iScience

Published: June 08, 2025

Clinical Characteristics and Impact on Prognosis of Melanoma Accompanied by Multiple Primary Malignancies: A Retrospective Analysis.

Clinical Characteristics and Impact on Prognosis of Melanoma Accompanied by Multiple Primary Malignancies: A Retrospective Analysis.

Journal: Cancer investigation

Published: May 23, 2025

Bridging Data Gaps in Oncology: Large Language Models and Collaborative Filtering for Cancer Treatment Recommendations.

Bridging Data Gaps in Oncology: Large Language Models and Collaborative Filtering for Cancer Treatment Recommendations.

Journal: medRxiv : the preprint server for health sciences

Published: April 29, 2025

Showing 1-12 of 188

Last Updated: 09/26/2026